AIM ImmunoTech Inc.
AIM
$0.119
-$0.001-0.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 52.66% | 62.60% | -58.89% | -186.53% | -22.41% |
| Total Depreciation and Amortization | 18.87% | -23.75% | 23.40% | -65.88% | 89.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.21% | 588.37% | 130.97% | -35.80% | -52.40% |
| Change in Net Operating Assets | -80.08% | -179.85% | 180.59% | 171.64% | 83.22% |
| Cash from Operations | 45.16% | -39.39% | -30.84% | -60.78% | -14.15% |
| Capital Expenditure | -80.00% | -- | -- | 102.59% | -103.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -98.79% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 220.96% | 493.33% | -47.66% | -79.47% | -482.00% |
| Cash from Investing | 199.40% | 504.90% | -102.56% | -106.36% | -234.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.28% | 10,440.00% | 229.00% | -- | 832.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.20% | 48,720.00% | 2,729.00% | -- | 832.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 54.30% | 110.99% | 41.39% | -263.08% | -23.03% |
